NIA AD/ADRD R21 Exploratory Research Grant
Supports exploratory Alzheimer's and dementia studies in the United States for high-risk, novel research directions.
PAR-25-331, titled Research on Current Topics in Alzheimer's Disease and AD-Related Dementias (R21 Clinical Trial Optional), is NIA's parent NOFO for exploratory and developmental R21 grants in the AD/ADRD space. The R21 mechanism supports up to two years of high-risk, novel research that is not yet ready for the longer commitment of an R01. Released December 30, 2024 and expiring November 17, 202…
Exploratory and developmental research on current priority topics in Alzheimer's disease and related dementias, as defined by active NOSIs attached to PAR-25-331.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see the timeline
Guides for this application
All guides →NIH Biosketch Guide: Format, SciENcv Steps, and Examples
Learn what an NIH biosketch is, how the format works, what to prepare for SciENcv, and how startup teams should avoid common biosketch mistakes.
Write proposalHow to Write a Specific Aims Page
Learn how to write a specific aims page for NIH, SBIR-adjacent, and translational R&D grants, with structure, reviewer logic, examples, and common mistakes.
Where to applyGrants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
Submit & reportSAM.gov Registration and UEI Guide for Federal Grant Applicants
Learn how SAM.gov registration, UEI numbers, Grants.gov accounts, organization profiles, workspace roles, and renewal timing fit together.
More from NIA
All grants from this funder →2026 NIA Mentorship Prize Competition
🇺🇸NIA · United States
Pays $100,000 to each of up to six faculty mentors recognized for outstanding aging-research mentorship.
NIA SBIR Phase I
🇺🇸NIA · United States
Supports small businesses developing aging and memory technologies at the feasibility stage.
NIA SBIR Phase II
🇺🇸NIA · United States
Funds small businesses advancing aging biology and Alzheimer's disease technologies through full development execution.
NIA STTR Phase I
🇺🇸NIA · United States
Supports small businesses partnering with universities on aging innovation at feasibility stage.
NIA Alzheimer's Drug-Development Program
🇺🇸NIA · United States
Funds collaborative research alliances that accelerate Alzheimer's drug development in the United States.
NIA R01: Drug Repositioning and Combination Therapy for Alzheimer's Disease
NIA · United States
Funds researchers combining computational and experimental approaches to test repositioned drugs for Alzheimer's disease treatment through NIH R01 grants.
Similar grants
Browse the directory →
NIDCD R21 Exploratory/Developmental Research Grant
🇺🇸NIDCD · United States
Supports early exploratory methods and technologies for communication science in the United States.
NICHD R21 Exploratory/Developmental Grant
🇺🇸NICHD · United States
Supports high-risk exploratory projects in NICHD research areas through small pilot grants in the United States.
GRA I&E Exploratory Grant
🇺🇸GRA · United States
Supports Georgia university researchers with feasibility testing and demand validation funding.
NICHD R01 Research Project Grant
🇺🇸NICHD · United States
Supports investigator-led biomedical studies across the NICHD portfolio in the United States.
NIDCD R01 Research Project Grant
🇺🇸NIDCD · United States
Funds investigator-led research on hearing, balance, taste, smell, voice, speech, and language through major grants.
NEI R01 Research Project Grant
🇺🇸NEI · United States
Funds investigator-led basic and clinical vision science at research institutions across the United States.